|
2024
|
P/S
|
Deodorants for human beings |
|
2023
|
Invention
|
Pharmaceutical formulations.
The pharmacokinetic profile of the SGLT2 inhibitor bexagliflozin ca... |
|
2022
|
P/S
|
pharmaceutical preparations for the treatment of diabetes |
|
2021
|
Invention
|
Pharmaceutical formulations. The pharmacokinetic profile of the SGLT2 inhibitor bexagliflozin can... |
|
2020
|
P/S
|
Pharmaceutical preparation for the treatment of diabetes |
|
2019
|
Invention
|
Crystalline form of benzylbenzene sglt2 inhibitor. Provided are crystalline forms of a compound h... |
|
2016
|
Invention
|
Preparation of hydroxy-benzylbenzene derivatives. Methods for preparing intermediates of SGLT2 in... |
|
2015
|
Invention
|
Process for the preparation of benzylbenzene sglt2 inhibitors. Provided are methods of making com... |
|
2013
|
Invention
|
Benzylbenzene derivatives and methods of use. Provided are compounds having an inhibitory effect ... |
|
|
Invention
|
Process for preparation of benzylbenzene sodium-dependent glucose cotransporter 2 (sglt2) inhibit... |
|
2012
|
Invention
|
Processes for the preparation of sglt2 inhibitors. Provided are processes for the preparation of ... |
